Abiomed (ABMD) stock Forecast for 2021 – 2025

Abiomed (ABMD) stock Forecast for 2022 – 2026

Last update: February 6, 2023 (10:37)

Sector: Healthcare

The share price of Abiomed, Inc. (ABMD) now

What analysts predict: $363
52-week High/Low: $381.99 / $219.85

50/200 Day Moving Average: $351.42 / $291.67

This figure corresponds to the Average Price over the previous 50/200 days. For Abiomed stocks, the 50-day moving average is the support level today.

For Abiomed stocks, the 200-day moving average is the support level today.

Are you interested in Abiomed, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Abiomed stock price in 2023, 2024, 2025, 2026, 2027. How much will one Abiomed share be worth in 2023 - 2027?

When should I take profit in Abiomed stock? When should I record a loss on Abiomed stock? What are analysts' forecasts for Abiomed stock? What is the future of Abiomed stock? We forecast Abiomed stock performance using neural networks based on historical data on Abiomed stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Abiomed stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Abiomed shares. This happens once a day.


Sell or Buy Abiomed (ABMD) stocks? Analytic Experts Forecasting...

Abiomed Stock Buy or Sell? ABMD Stocks Analytic Forecasts
February 6, 2023

We present you the most up-to-date and complete review of analytical trend forecasts and views on the ABMD stock market. … Read more



Historical and forecast chart of Abiomed stock

The chart below shows the historical price of Abiomed stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Abiomed stock price can be found in the table below.

Long-term forecasts by years.

Abiomed daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 08 384.74 380.99 388.40 1.94
Feb 09 381.86 376.61 389.49 3.42
Feb 10 386.63 379.67 394.17 3.82
Feb 11 390.21 382.60 398.01 4.03
Feb 12 398.79 395.30 402.98 1.94
Feb 13 402.18 399.06 409.52 2.62
Feb 14 402.38 399.46 407.41 1.99
Feb 15 399.87 395.77 405.46 2.45
Feb 16 400.47 392.46 405.17 3.24
Feb 17 395.76 389.73 403.18 3.45
Feb 18 389.63 385.73 394.50 2.27
Feb 19 396.83 393.96 400.90 1.76
Feb 20 393.96 389.13 396.62 1.92
Feb 21 400.26 394.16 403.36 2.34
Feb 22 405.46 401.82 409.01 1.79
Feb 23 409.01 405.13 415.35 2.52
Feb 24 411.67 404.78 416.92 3.00
Feb 25 411.88 403.85 417.85 3.47
Feb 26 402.92 398.39 410.57 3.06
Feb 27 402.41 397.89 410.46 3.16
Feb 28 401.21 395.79 404.22 2.13
Mar 01 398.50 392.02 405.07 3.33
Mar 02 401.79 399.07 408.32 2.32
Mar 03 399.78 397.18 407.07 2.49
Mar 04 396.18 389.84 398.46 2.21
Mar 05 391.72 387.81 396.52 2.25
Mar 06 383.89 381.30 390.70 2.47
Mar 07 385.42 379.16 387.54 2.21
Mar 08 385.62 379.25 392.65 3.53
Mar 09 377.71 371.67 383.00 3.05

Abiomed Daily Price Targets


Abiomed Stock Forecast 02-08-2023.

Forecast target price for 02-08-2023: $384.74.
Positive dynamics for Abiomed shares will prevail with possible volatility of 1.907%.
Pessimistic target level: 380.99
Optimistic target level: 388.40

Abiomed Stock Forecast 02-09-2023.

Forecast target price for 02-09-2023: $381.86.
Negative dynamics for Abiomed shares will prevail with possible volatility of 3.309%.
Pessimistic target level: 376.61
Optimistic target level: 389.49

Abiomed Stock Forecast 02-10-2023.

Forecast target price for 02-10-2023: $386.63.
Positive dynamics for Abiomed shares will prevail with possible volatility of 3.678%.
Pessimistic target level: 379.67
Optimistic target level: 394.17

Abiomed Stock Forecast 02-11-2023.

Forecast target price for 02-11-2023: $390.21.
Positive dynamics for Abiomed shares will prevail with possible volatility of 3.873%.
Pessimistic target level: 382.60
Optimistic target level: 398.01

Abiomed Stock Forecast 02-12-2023.

Forecast target price for 02-12-2023: $398.79.
Positive dynamics for Abiomed shares will prevail with possible volatility of 1.905%.
Pessimistic target level: 395.30
Optimistic target level: 402.98

Abiomed Stock Forecast 02-13-2023.

Forecast target price for 02-13-2023: $402.18.
Positive dynamics for Abiomed shares will prevail with possible volatility of 2.553%.
Pessimistic target level: 399.06
Optimistic target level: 409.52

ABMD (ABMD) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Mar. 369.04 355.55 386.29 7.96
Apr. 362.45 343.35 372.31 7.78
May. 347.05 323.74 364.45 11.17
Jun. 352.65 337.06 363.14 7.18
Jul. 338.86 327.34 361.04 9.33
Aug. 346.06 329.30 369.30 10.83
Sep. 361.65 353.97 382.25 7.40
Oct. 358.58 334.50 364.98 8.35
Nov. 366.50 347.81 376.78 7.69
Dec. 382.39 371.99 401.89 7.44

Abiomed forecast for this year


Abiomed Stock Prediction for Mar 2023

An downtrend is forecast for this month with an optimal target price of $369.037. Pessimistic: $355.55. Optimistic: $386.29


Abiomed Stock Prediction for Apr 2023

An downtrend is forecast for this month with an optimal target price of $362.45. Pessimistic: $343.35. Optimistic: $372.31


Abiomed Stock Prediction for May 2023

An downtrend is forecast for this month with an optimal target price of $347.046. Pessimistic: $323.74. Optimistic: $364.45


Abiomed Stock Prediction for Jun 2023

An uptrend is forecast for this month with an optimal target price of $352.65. Pessimistic: $337.06. Optimistic: $363.14


Abiomed Stock Prediction for Jul 2023

An downtrend is forecast for this month with an optimal target price of $338.862. Pessimistic: $327.34. Optimistic: $361.04


Abiomed Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $346.062. Pessimistic: $329.30. Optimistic: $369.30


Abiomed Stock Prediction for Sep 2023

An uptrend is forecast for this month with an optimal target price of $361.653. Pessimistic: $353.97. Optimistic: $382.25


Abiomed Stock Prediction for Oct 2023

An downtrend is forecast for this month with an optimal target price of $358.579. Pessimistic: $334.50. Optimistic: $364.98


Abiomed Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $366.503. Pessimistic: $347.81. Optimistic: $376.78


Abiomed Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $382.391. Pessimistic: $371.99. Optimistic: $401.89



Abiomed (ABMD) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 375.24 367.90 395.65 7.01
Feb 351.32 342.66 373.42 8.24
Mar 374.91 350.69 389.57 9.98
Apr 388.61 365.49 401.83 9.04
May 381.35 370.97 391.39 5.22
Jun 401.44 375.51 416.80 9.91
Jul 409.63 400.58 426.00 5.97
Aug 408.59 388.10 422.13 8.06
Sep 431.16 402.58 451.32 10.80
Oct 425.67 414.09 437.61 5.37
Nov 422.41 396.56 446.46 11.18
Dec 439.28 430.70 456.46 5.64

Abiomed (ABMD) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 417.25 402.71 445.27 9.56
Feb 402.00 385.60 424.21 9.10
Mar 411.57 386.38 428.01 9.73
Apr 410.17 397.27 420.98 5.63
May 445.04 434.07 456.38 4.89
Jun 415.15 401.04 441.62 9.19
Jul 406.33 382.50 420.15 8.96
Aug 384.92 363.65 408.47 10.97
Sep 363.98 348.82 385.94 9.62
Oct 360.88 348.61 381.13 8.53
Nov 382.66 371.93 396.97 6.31
Dec 386.57 375.72 410.55 8.48

Abiomed (ABMD) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 372.44 356.61 393.65 9.41
Feb 394.91 373.09 402.63 7.34
Mar 426.47 404.72 452.93 10.64
Apr 455.83 437.62 486.83 10.11
May 470.55 452.15 493.75 8.42
Jun 444.15 415.84 470.20 11.56
Jul 448.31 437.26 459.36 4.81
Aug 458.98 434.01 487.07 10.89
Sep 466.39 455.29 476.70 4.49
Oct 500.48 483.04 523.03 7.65
Nov 490.27 464.02 522.36 11.17
Dec 509.44 485.19 536.29 9.53

Abiomed (ABMD) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 545.38 527.77 571.34 7.63
Feb 546.31 532.38 559.31 4.82
Mar 569.99 537.53 608.27 11.63
Apr 593.25 569.04 605.35 6.00
May 632.58 601.93 656.78 8.35
Jun 644.41 607.71 681.66 10.85
Jul 643.86 600.63 661.38 9.19
Aug 594.06 574.37 607.19 5.41
Sep 556.19 538.70 591.65 8.95
Oct 548.62 522.51 574.27 9.01
Nov 571.47 553.99 593.33 6.63
Dec 577.79 540.96 594.98 9.08

Abiomed information and performance

Abiomed is a manufacturer of medical implants, including the AbioCor artificial heart and impella. The company is headquartered in Danvers, Massachusetts and has three subsidiary offices: two in Germany in Berlin and Aachen and one in Japan. Michael R. Minogue joined Abiomed in 2004 and serves as CEO, Chairman and President.

Abiomed Address

22 CHERRY HILL DR, DANVERS, MA, US

Market Capitalization: 17 180 649 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 274 184 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 65.36

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.75

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 5.83

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.871
Quarterly Revenue Growth YOY: 0.072
Trailing PE: 65.36

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 15.19

Enterprise Value (EV) /Revenue

EV To EBITDA: 57.94

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 45091200

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.